Cilazapril in Congestive Heart Failure
- 1 January 1991
- journal article
- clinical trial
- Published by Springer Nature in Drugs
- Vol. 41 (1) , 54-61
- https://doi.org/10.2165/00003495-199100411-00010
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Delayed reversal of impaired vasodilation in congestive heart failure after heart transplantationThe American Journal of Cardiology, 1988
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Biological Properties of the Angiotensin-Converting Enzyme Inhibitor CilazaprilJournal of Cardiovascular Pharmacology, 1985
- Effects of Enalapril on Clinical Status, Biochemistry, Exercise Performance and Haemodynamics in Heart FailureDrugs, 1985
- Lack of relationship between the short-term hemodynamic effects of captopril and subsequent clinical responses.Circulation, 1984
- Hemodynamic and clinical response to enalapril, a long-acting converting-enzyme inhibitor, in patients with congestive heart failure.Circulation, 1984
- A placebo-controlled trial of captopril in refractory chronic congestive heart failureJournal of the American College of Cardiology, 1983
- Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study.Circulation, 1983
- Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.Circulation, 1980
- A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failureJournal of Clinical Investigation, 1968